Form 4: Xylem SVP Rodney Aulick Reports Stock and Option Awards

Rodney Aulick, SVP & President, WSS at Xylem Inc., reports the acquisition of restricted stock units and stock options.

Summary

• Rodney Aulick, a Senior Vice President at Xylem Inc., filed a Form 4 disclosing transactions related to the company's stock.
• On March 1, 2024, Aulick acquired 1,661 shares of common stock at a price of $127.94 per share.
• These shares were awarded as restricted stock units under the Xylem 2011 Omnibus Incentive Plan, vesting in equal installments on March 1, 2025, March 1, 2026, and March 1, 2027.
• Additionally, Aulick acquired 5,619 non-qualified stock options, also at an exercise price of $127.94, vesting on the same schedule as the restricted stock units.
• Following these transactions, Aulick directly owns 82,156 shares of Xylem Inc. common stock and 5,619 stock options.
• The filing was signed on Aulick's behalf by Seaneen Cline, under a power of attorney dated November 7, 2023.

Sentiment

Score: 7

Explanation: The document reflects standard executive compensation practices, which is generally viewed neutrally to positively as it aligns management with shareholder interests. There are no indications of negative performance or concerns.

Positives

• The grant of restricted stock units and stock options aligns Aulick's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the executive.

Future Outlook

The document does not contain specific forward-looking statements regarding the company's future performance, but the vesting schedule of the stock options and restricted stock units suggests an expectation of continued service and contribution from the executive.

Industry Context

Executive compensation in the form of stock options and restricted stock units is a common practice in publicly traded companies to incentivize performance and align management's interests with those of shareholders. This filing reflects standard compensation practices.

Comparison to Industry Standards

• Stock option and restricted stock unit grants are common compensation tools for executives in publicly traded companies like Xylem.
• Companies such as Danaher, Agilent, and Thermo Fisher Scientific also utilize similar equity-based compensation plans to incentivize their executives.
• The vesting schedules, typically three to four years, are in line with industry standards to promote long-term commitment.

Stakeholder Impact

• Shareholders may view the equity grants positively as they align management's interests with long-term company performance.
• Employees may see this as a standard part of executive compensation.

Key Dates